HONG KONG, Ephreli 17, 2024 – (ACN Newswire) – I-China Isotope & Radiation Corporation (“CIRC” noma “Inkampani” , kanye nezinkampani ezingaphansi kwayo, “Iqembu”; Ikhodi Yesitoko: 1763.HK) imemezela izitatimende zezimali ezihlanganisiwe zeQembu zonyaka ophele zingama-31 kuZibandlela wezi-2023 (“ 2023” noma “Isikhathi Sokubika”).

Ngonyaka ophele zingama-31 kuZibandlela wezi-2023, iQembu liqhube izingxenye ezinhlanu zebhizinisi, okuyimithi, imikhiqizo yomthombo wemisebe, imisebe, imishini yokwelapha ngemisebe kanye nezinsizakalo ezihlobene namanye amabhizinisi. Ngo-2023, iQembu laqhubeka nokuqinisa imizamo yethu yokuthuthukisa izimakethe futhi lazuza ukukhula okuqhubekayo ekusebenzeni kahle komnotho. Ngonyaka wezi-2023, iQembu liqophe imali engenayo engu-RMB6.635 wezigidigidi, emele ukunyuka konyaka ngo-7.8%; inzuzo eyisamba ibingu-RMB3,482.2 wezigidi, isamba semali sasingu-52.5%; ithole inzuzo eyizigidi ezingu-RMB776.1, emele ukukhula konyaka ngonyaka ngo-2.8%, nenzuzo isiyonke edalwe yinkampani engumzali ezuze u-RMB371.0 wezigidi.

Ingxenye Yezemithi: Intuthuko enhle kakhulu ezimbonini ezikhona kanye namabhizinisi anokwanda okuqinile komthelela wezimboni

Ngo-2023, mayelana nengxenye yezemithi, iQembu lahlinzeka ngokuhlinzekwa okuzinzile kwe-radiopharmaceuticals ezikhungweni zezokwelapha zasekhaya futhi laqinisa ukugqugquzelwa kokuxilongwa kwemithi yenuzi kanye nobuchwepheshe bokwelapha eminyangweni yezokwelapha nakweminye imisebenzi yokuthuthukiswa kwezimakethe, kuyilapho liqhubeka likhuthaza intuthuko ezimbonini nasemabhizinisini akhona. . Ngezingqungquthela zemfundo nezinye izindlela, IQembu lenze ukuthandwa kwesayensi kumphakathi jikelele kanye namakhasimende emithi yenuzi emikhiqizweni emisha efana "ne-therapy ye-sodium iodine-131 capsule" kanye ne-radionuclide yesayensi, ithuthukisa ithonya layo emkhakheni wezokwelapha zenuzi. NgoZibandlela wezi-2023, i-capsule ye-sodium iodine-131 yokwelapha ekhiqizwe yi-HTA Co., Ltd., inkampani engaphansi kweQembu, ingene ngempumelelo ohlwini lwezidakamizwa lukazwelonke lwe-Basic Medical Insurance, Umshwalense Wokulimala Okuhlobene Nomsebenzi kanye Nomshuwalense Wokubeletha (2023) izidakamizwa ezimbozwe izingxoxo zomshwalense wezempilo kazwelonke.

Phakathi Nenkathi Yokubika, Iqembu liqophe izigidi ezingu-RMB4,128.6 emalini engenayo evela ekuthengisweni kwemithi, emele ukunyuka konyaka ngo-5.2%, okubalelwa ku-62.2% wesamba semali engenayo, eqophe izigidi ezingu-RMB1,682.8 emalini engenayo evela ekuxilongweni kwezithombe. kanye nama-radiopharmaceuticals okwelapha, amele ukukhula konyaka nonyaka ngo-15.3%, futhi aqopha u-RMB2,323.8 wezigidi zemali engenayo evela ekuhlolweni kokuphefumula.

Ibhizinisi lemikhiqizo yomthombo we-radioactive: Ihlinzeka ngempumelelo insizakalo yomkhumbi-mkhathi ophethwe i-Shenzhou XV futhi ihlale inesabelo esikhulu semakethe

Ngo-2023, umthombo osekelayo okhipha imisebe owathuthukiswa yiQembu lomkhumbi-mkhathi ophethwe i-Shenzhou XV wenza ngendlela egculisayo ngesikhathi somkhankaso ngokuqinisekisa umyalo onembile wokushisisa wenjini yokuguqula i-thrust reverser ngedivayisi yokulawula i-Y-altitude kanye nokuhlala okuphephile nokuthambile kwe-capsule ebuyayo, ngaleyo ndlela. eqinisekisa ukuphothulwa ngempumelelo kwemishini ye-Shenzhou XV eyenziwe ngabantu. Ubuchwepheshe bokusebenzisa kabusha umthombo okhipha imisebe osewathatha umhlalaphansi buye benza umnikelo oncomekayo emkhakheni wocwaningo olusetshenziswayo ngomnotho oyindilinga, futhi bazuza Umklomelo Wokuqala Wesifundazwe saseSichuan Umklomelo Ophansi Wesayensi Yekhabhoni Nobuchwepheshe. Phakathi Nenkathi Yokubika, uhlobo olusha lwemithombo yegeji ye-krypton [85kr] ekhiqizwe ekhaya yethulwa ngokusemthethweni emakethe.

Phakathi Nenkathi Yokubika, Iqembu liqophe izigidi ezingu-RMB586.2 emalini engenayo evela emikhiqizweni yemithombo yemisebe, emele ukukhula konyaka nonyaka ngo-0.9%. Umthombo wommese we-Gamma kanye nomthombo wokuhlola ongonakalisi okhipha imisebe usalokhu uyisabelo semakethe esizinzile nesiphezulu, uzuza ukukhula kwemali engenayo, lapho umthombo wommese we-gamma wathola imali yokusebenza yezigidi ezingu-RMB73 kanye nokuhlola okungabhubhisi umthombo okhipha imisebe wathola imali engenayo yokusebenza kwezigidi ezingu-RMB89.

Ibhizinisi le-Irradiation: Ngokuqhubekayo lisungula indlela yokubambisana kanye nenzuzo yokuthengisa yemikhiqizo emisha efinyelela irekhodi eliphezulu

Ngo-2023, iNkampani yenza ubuhlakani ngendlela yokubambisana futhi yenza imizamo ejulile yokubeka ibhizinisi layo futhi ihlole imboni yokwelapha ye-EB, okwaholela ekuphothulweni kwesu nomugqa wokukhiqiza wamapuleti e-EB, ngenkathi ihlela amapuleti ahlanganiswe ngemibala e-EB. kanye nefilimu ye-EB ukuze kwakhiwe i-EB yokwelapha i-ecosystem yezimboni. I-BINE High-Tech Co., Ltd., inkampani engaphansi kweQembu, iqede ngempumelelo ukugcinwa kokuthengiswa kwangemuva kokuthengiswa kwemishini yokufaka imisebe ye-curies ye-BFT gamma eyizigidi ezi-4 ye-Grand Ten Holdings e-Malaysia, okuwumsebenzi wokuqala wokuthekelisa we-BINE High-Tech. Co., Ltd. futhi igcine ukusebenza okuphephile iminyaka eyi-10 ngaphandle kwanoma yisiphi isigameko.

Phakathi Nenkathi Yokubika, IQembu lahlola imakethe yomkhiqizo wokushiswa kwemisebe ngenkuthalo, ngemali engenayo yokuthengisa yemikhiqizo emisha yokuthela imisebe ikhuphuke yafinyelela ngaphezu kwezigidi ezingu-RMB28.5, yafinyelela irekhodi eliphezulu. Iqembu liqophe imali eyizigidi ezingu-RMB170.8 ebhizinisini elihlobene nokushiswa kwemisebe.

Imishini yokwelapha ngemisebe kanye nezinsizakalo ezihlobene: Ukusheshisa inqubo yokukhiqiza yasekhaya yemishini ye-radiotherapy ephezulu futhi umkhiqizo wokuqala uthole ukugunyazwa ngempumelelo.

Ngo-2023, iQembu lasheshisa inqubo yokukhiqiza yasekhaya yemishini ye-radiotherapy ephezulu. Ngomhla zingama-28 kuSepthemba 2023, i-CNNC Accuray (Tianjin) Medical Technology Co., Ltd. (“CNNC Accuray”), inkampani ephethwe yiQembu, ithole ngempumelelo isitifiketi sokubhaliswa kwedivayisi yezokwelapha esikhishwe i-National Medical Products Administration ngenxa yezinga layo eliphezulu lasekhaya. i-spiral tomotherapy system (TOMO C). Lo mkhiqizo usube umkhiqizo wokuqala wasekhaya we-spiral tomotherapy emkhakheni wezokwelapha osezingeni eliphezulu eChina. Umcimbi osemthethweni wokwethulwa kokukhiqizwa ngobuningi kanye nomhlangano wokushintshisana kwabatshalizimali we-TOMO C wawubanjelwe e-Tianjin zingama-25 kuMfumfu.

Ukwengeza, i-CNHE-MDR, umphumela wocwaningo nokuthuthukiswa kwephrojekthi yesistimu yokuthwebula izithombe ze-X-ray yedijithali yedijithali, yagunyazwa ngoJuni 2023 futhi yathola isitifiketi sokubhaliswa kwemishini yezokwelapha. Iphrojekthi ye-Smart Cobalt-60-based Cone Beam Focused Stereotactic Therapy System iqedele ukuhlola uhlobo lomkhiqizo futhi yangena esigabeni sesilingo somtholampilo ngokushelela. Iphrojekthi ye-SPECT/CT iphumelele ukuhlolwa okujwayelekile nokwamukelwa koMbuso Wezokuphathwa Kwesayensi, Ubuchwepheshe Nemboni Yezokuvikela Kukazwelonke, ngesilinganiso sokwamukelwa "esihle kakhulu".

NgeSikhathi Sokubika, IQembu liqophe izigidi ezingama-RMB933.7 emalini engenayo evela kumishini yezokwelapha yenuzi kanye nezinsiza ezihlobene nayo, emele ukukhula konyaka ngonyaka ngama-27.5%, futhi ibalelwa ku-14.1% wesamba semali engenayo, okuyenza ibe umthombo wesibili ngobukhulu imali engenayo.

Ibhizinisi lamazwe ngamazwe: Kancane kancane lijulisa ubukhona bomhlaba kanye nokwenza impumelelo emabhizinisini amaningana

Ngesikhathi Sokubika, iQembu lihlole imakethe yamazwe ngamazwe futhi lathumela ngaphandle izinto zokuhlola umoya, amakhithi e-radioimmunity, imishini yokukhipha ama-radiopharmaceuticals, imishini yezokwelapha namadivayisi kanye neminye imikhiqizo emazweni amaningi nasezifundeni ezifana ne-Indonesia, Brazil, Peru, Colombia, I-Ecuador, i-India, i-Bangladesh, i-Singapore kanye ne-Vietnam, ithola isamba semali engenayo yokuthunyelwa ngaphandle kwezigidi ezingu-RMB430. Imali engenayo yebhizinisi lamazwe ngamazwe evela emikhiqizweni evamile yezokwelapha igcine ukukhula okuphawulekayo ngo-2023.

Ukumaketha: Ukukhuthaza ukwakhiwa komkhiqizo ngendlela ehlelekile nokusebenzisa ngokugcwele inani lenkundla ye-IAEA

Phakathi Nenkathi Yokubika, Iqembu lajulisa imizamo yalo yokwakha umkhiqizo. NgoMeyi 2023, iQembu lahlela ngempumelelo “i-Sichuan Medical Isotopes kanye ne-Radiopharmaceutical Industry Development Summit” ngokubambisana neminyango eyisishiyagalombili esiFundazweni saseSichuan. NgoSepthemba 2023, IQembu laba nesandla futhi labamba iqhaza Engqungqutheleni Yokuthuthukiswa Kwekhwalithi Ephezulu Yemboni Yezicelo Zobuchwepheshe Benuzi, Iforamu Yesibili Yase-China-ASEAN Yokusetshenziswa Ngokuthula Kobuchwepheshe Benuzi, kanye nokunye. amadokhumenti okubambisana kwebhizinisi asayine, futhi abonisa imishini yezokwelapha yenuzi kanye nemibukiso yedijithali yemithi yenuzi. IQembu labamba iqhaza Engqungqutheleni Yonyaka Yezemfundo Yegatsha Lezokwelapha LeNuclear le-Chinese Medical Association ngo-2 ukwethula i-Radiant Intelligence 2023 Intelligent Nuclear Medicine System, futhi lasingatha ngokuhlanganyela Iforamu Yesibili Yamazwe Ngamazwe Yokuthuthukiswa Kwemboni Yezicelo Zobuchwepheshe Benuzi ngo-Okthoba 1.0. , okubonisa ngokugcwele ubuholi be-CIRC embonini yokufaka isicelo sobuchwepheshe benuzi.

Ngaphezu kwalokho, iQembu belisebenzisa ngenkuthalo inani lenkundla ye-IAEA Collaboration Center ukuze ithuthukise umthelela wayo emhlabeni jikelele. Ngo-Agasti 2023, iQembu lasingatha "Isifundo Sokuqeqeshwa Kwamazwe Ngamazwe Nge-Radiopharmaceuticals Preparation for the Asia-Pacific Region" egameni le-IAEA Collaboration Center for Radiopharmaceuticals and Radioactive Sources. IQembu liphikelele ekuguquleni isikhungo salo sokumaketha ukuze kugqugquzelwe intuthuko ehambisanayo, esezingeni eliphezulu futhi ephephile yebhizinisi layo kwezemithi yokwelapha ngemisebe, imithombo ekhipha imisebe kanye nezinhlayiya ezikhipha imisebe. Mayelana nokumakethwa kwama-nuclide asekhaya, izinsiza zangaphakathi zahlanganiswa futhi zahlanganiswa ukuze kukhiqizwe, kuthengiswe, kusatshalaliswe kanye nezinkonzo zamajeneretha asekhaya e-Lu-177 kanye ne-Ge/Ga, kwabeka isisekelo sokuthuthukiswa kwemakethe ngemva kokufinyelela amandla okuklama ngo-2024.

Ucwaningo lwesayensi kanye nokusungula izinto ezintsha: Amaphrojekthi amaningi aqhuba ukuhlolwa komtholampilo kanye nomsebenzi ohlobene nezakhiwo zobuhlakani athola inqubekelaphambili ebalulekile

IQembu belilokhu liqhuba umsebenzi wocwaningo nokuthuthukisa ngenkuthalo izinhlobo ezahlukene zokuxilongwa kwezithombe kanye nemithi yokwelapha ukuze kugcwaliswe izikhala emikhakheni ehlukahlukene yokwelashwa kanye nokuhlangabezana nezidingo zezokwelapha zaseChina. Kusukela ngomhla zingama-31 kuZibandlela wezi-2023, iQembu libe nenani lokuxilongwa kwezithombe kanye nemithi yokwelapha ye-radiopharmaceuticals ngaphansi kocwaningo nokuthuthukiswa. Phakathi kwazo, umjovo we-sodium fluorine usuqedile ukuhlolwa kwemitholampilo futhi wathunyelwa ukuze kusetshenziswe izidakamizwa ezintsha; umjovo we-iodine-MIBG wawusesivivinyweni somtholampilo seSigaba III; Umjovo we-technetium sulfide colloidal, umjovo we-Ga-Dotatate, umjovo we-fluorine betazine, umjovo we-fluorine stamine, umjovo we-fluorine-L we-dopa kanye nomjovo we-lutetium oxyoctreotide wagunyazwa esivivinyweni somtholampilo, kanye nezinhlobonhlobo zokuxilongwa kwe-imaging kanye nemithi yokwelapha ye-radiopharmaceuticals bekusesigabeni socwaningo kanye nentuthuko. .

Phakathi Nenkathi Yokubika, Iqembu lithole imiphumela emangalisayo emsebenzini ohlobene nezakhiwo zobuhlakani, kwasetshenziswa isamba samalungelo obunikazi angama-298, ukugunyazwa kwamalungelo obunikazi angama-240, okuhlanganisa ukugunyazwa kwelungelo lobunikazi bomklamo wangaphandle okungu-5. Kusukela zingama-31 kuZibandlela wezi-2023, iQembu belinamalungelo obunikazi asebenzayo angama-945, phakathi kwawo bekunamalungelo obunikazi okusungulwa okungu-149, asekela futhi athuthukisa amandla alo ezobuchwepheshe. Inkampani yayinezimpawu zokuthengisa ezibhalisiwe ezingu-11, amalungelo okushicilela angama-38, izinga likazwelonke elingu-1, izinga lemboni yamandla eli-1 kanye namazinga eqembu angu-6 akhishiwe, kanye nezinga likazwelonke elingu-1, izinga eli-1 lemboni yezolimo, amazinga angu-4 emboni yenuzi kanye namazinga eqembu angu-12 alungiswayo/azokhishwa.

Mayelana nemiklomelo kanye nokuhlonishwa kwezobuchwepheshe, phakathi neNkathi Yokubika, iQembu liwine indondo yezobuchwepheshe yesifundazwe neyongqongqoshe, izindondo ezi-1 zesayensi yezenhlalo nobuchwepheshe, indondo eyodwa yezinga leqembu lesayensi nobuchwepheshe, kanye nemiklomelo emi-4 emqhudelwaneni we-CNNC Science and Innovation.

Outlook

Uma sibheka phambili, i-CIRC izonikeza ukudlala okugcwele ezinzuzweni eziyingqayizivele zemithi yenuzi ekuxilongeni nasekwelapheni izifo ezinkulu njengezifo ze-neurodeergenerative, izifo zenhliziyo nemithambo yegazi kanye nezimila eziyingozi, futhi inikeze ngemikhiqizo esezingeni eliphezulu, izinsizakalo kanye nezixazululo ezididiyelwe zokuvikela kangcono izimpilo zabantu. kanye nempilo kanye nokwenza lula ukwakhiwa kwe "Healthy China".

Ngo-2024, iNkampani izowabamba ngokuqinile amathuba entuthuko, ingagodli, ukuze ilondoloze umfutho omuhle wokukhula, yenze yonke imizamo yokuthuthukisa ukusebenza komnotho kube irekhodi eliphezulu futhi ithuthukise amakhono amasha kanye namakhono okudala inani, iqinise ngokuqhubekayo imisebenzi ewumgogodla. futhi sithuthukise ukuncintisana okuyinhloko, futhi senze izindima ezintathu ezinkulu zokusungula izinto ezintsha kwezesayensi nezobuchwepheshe, ukulawula imboni, nokusekelwa kwezokuphepha, ukuze kufezwe izinjongo zokuhlela nemisebenzi futhi kusheshiswe ukusungulwa kwemikhiqizo namasevisi esicelo sobuchwepheshe be-isotope nobuchwepheshe bemisebe eyaziwa emhlabeni wonke. iqembu lokuhlinzeka.

Mayelana ne-China Isotope & Radiation Corporation

I-China Isotope & Radiation Corporation (ebizwa ngokuthi “CIRC” noma “Inkampani”) kusukela yasungulwa ngo-1983, izinikele ekuhloleni nasekuthuthukiseni izicelo zobuchwepheshe benuzi. Ngokuziqhayisa ngeminyaka engama-40 yesipiliyoni sembonini, Inkampani isivele njengomholi ovelele embonini yasekhaya yobuchwepheshe benuzi. IQembu libambe iqhaza kakhulu ocwaningweni, ekuthuthukisweni, ekukhiqizeni nasekudayiseni imithi yomsakazo yokuxilonga kanye neyokwelapha kanye nemikhiqizo yomthombo wama-radioactive yezinhlelo zokusebenza zezokwelapha nezezimboni, ukuhlinzekwa kwensizakalo yokuthela inzalo ngenjongo yokuvala inzalo kanye nobunjiniyela, ukuthenga nokwakha (“EPC”) isevisi. ukuklama, ukukhiqiza kanye nokufakwa kwezindawo zokushiswa kwe-gamma ray kanye nokuhlinzekwa kwempahla yezokwelapha yenuzi kanye nezinsizakalo ezifana nezinsizakalo ezizimele zelabhorethri yomtholampilo ezibhedlela nakwezinye izikhungo zezokwelapha.

Imboni yezokwelapha zenuzi iyimboni enamandla amakhulu, umkhawulo onzima, kanye nenzuzo ephezulu. Njengomholi embonini yemithi yenuzi yaseShayina, i-CIRC ingumkhiqizi wasekhaya omkhulu kunabo bonke abakhiqiza i-imaging diagnostic and therapeutic radiopharmaceuticals, izinsiza zokuxilonga ze-UBT nezihlaziyi zokuhlola, kanye nezinsiza zokuhlaziya i-radioimmunity. Emkhakheni wemikhiqizo yomthombo wemisebe, iyona kuphela ibhizinisi eliwumnyombo emkhakheni wocwaningo lomthombo okhipha imisebe nokusebenzisa amandla okucwaninga nokukhiqiza. Emkhakheni wemisebe, ingeyesithathu ngobukhulu umhlinzeki wesevisi yokucubungula imisebe e-China, futhi iwukuphela komnikezeli e-China ohlinzeka ngokukhiqiza okhuphuka nomfula kanye nezinsizakalo zokuklama ezansi nomfula kanye nokufaka imishini yemisebe. Futhi izinkampani ezingaphansi kwayo ezimbili zigunyazwe uMnyango Wezemvelo Nezemvelo we-People's Republic of China njengabahlinzeki besevisi ababili kwabathathu be-EPC abagunyazwe ukuzibandakanya ekwakhiweni, ekukhiqizeni, nasekufakeni okokusebenza kwemisebe.

Isihloko: Isifinyezo sokukhishwa kwabezindaba

Imikhakha: Izimali Zansuku zonke, Daily News

https://www.acnnewswire.com

Kusuka ku-Asia Corporate News Network

Imininingwane © 2024 ACN Newswire. Wonke Amalungelo Agodliwe. Ukuhlukaniswa kwe-Asia Corporate News Network.

• I-SEO Powered Content & PR Distribution. Khuliswa Namuhla.
• I-PlatoData.Network Vertical Generative Ai. Zinike Amandla. Finyelela Lapha.
• I-PlatoAiStream. I-Web3 Intelligence. Ulwazi Lukhulisiwe. Finyelela Lapha.
• I-PlatoESG. Ikhabhoni, I-CleanTech, Amandla, Environment, Ilanga, Ukuphathwa Kwemfucuza. Finyelela Lapha.
• I-PlatoHealth. I-Biotech kanye ne-Clinical Trials Intelligence. Finyelela Lapha.
• Source: https://www.acnnewswire.com/press-release/english/90307/